Business /

Money

IPO

Hong Kong’s IPO juggernaut projected to raise up to US$45 billion in 2026: KPMG

It will be a pivotal year for hi-tech listings, which will help cement Hong Kong’s place at the top of global markets, auditing firm says.

China’s Fosun Pharma unit strikes US$2.1 billion obesity drug deal with Pfizer

China’s cautious shoppers continue to challenge consumer brands

Makers of fast-moving goods must look to lower-tier cities for growth as deflation persists, Bain & Co and Kantar Worldpanel say.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW